🇺🇸 FDA

Company profile · Sponsor

Oruka

Oruka Therapeutics

ORKA · NYSE pharma MENLO PARK, CA, USA
Pipeline
6
Drugs
0
Patents
0

Quick answer

Oruka (ORKA) is a pharma company. headquartered in MENLO PARK, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ORKA
Exchange NYSE
Company type pharma
Headquarters MENLO PARK, CA, USA
SEC CIK 0000907654

Pipeline (6)

Search pipeline →

  1. ORKA-001

    Oruka

    Plaque Psoriasis

    phase 2 small molecule active

    2 trials

  2. ORKA-001 Induction Dose

    Oruka

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  3. ORKA-001, Placebo for ORKA-001

    Oruka

    Moderate-to-Severe Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  4. ORKA-002

    Oruka

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  5. ORKA-001

    Oruka

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  6. ORKA-002

    Oruka

    Healthy Volunteers

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Oruka?

Oruka (ORKA) is a pharma company. headquartered in MENLO PARK, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Oruka sponsor?

We track 6 ClinicalTrials.gov-linked programs for Oruka, including ORKA-001 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Oruka company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.